Orient Pharma Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 427.23 million compared to TWD 295.09 million a year ago. Net income was TWD 0.203 million compared to TWD 19.53 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.4 TWD | +0.79% | -6.10% | +27.00% |
Apr. 15 | Orient Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+27.00% | 173M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 4166 Stock
- News Orient Pharma Co., Ltd.
- Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023